Prostate Cancer Reports
54

Volume 6 Number 3
March 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 3, March



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS

.

Albisinni S, Aoun F, Marcelis Q, Jungels C, Al Hajj Obeid W, Zanaty M, Tubaro A, Roumeguere T, DE Nunzio C.
Innovations in imaging modalities for recurrent and metastatic prostate cancer: a systematic review.
Minerva Urol Nefrol. 2018 Jan 31. doi: 10.23736/S0393-2249.18.03059-X. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Cuccurullo V, di Stasio GD, Evangelista L, Ciarmiello A, Mansi L.
Will 68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update.
Rev Esp Med Nucl Imagen Mol. 2018 Feb 2. pii: S2253-654X(17)30236-6. doi: 10.1016/j.remn.2017.10.008. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Gillebert Q, Huchet V, Rousseau C, Cochet A, Olivier P, Courbon F, Gontier E, Nataf V, Balogova S, Talbot JN; other ICHOROPRO investigators.
18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study.
PLoS One. 2018 Feb 9;13(2):e0191487. doi: 10.1371/journal.pone.0191487. eCollection 2018.
Source | Abstract | Full text | Similar articles



.

Hoffmann MA, Miederer M, Wieler HJ, Ruf C, Jakobs FM, Schreckenberger M.
Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT.
Oncotarget. 2017 Nov 14;8(67):111073-111083. doi: 10.18632/oncotarget.22441. eCollection 2017 Dec 19.
Source | Abstract | Full text | Similar articles



,

Lenzo NP, Meyrick D, Turner JH.
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.
Diagnostics (Basel). 2018 Feb 11;8(1). pii: E16. doi: 10.3390/diagnostics8010016.
Source | Abstract | Full text | Similar articles



.

Sachpekidis C, Bäumer P, Kopka K, Hadaschik BA, Hohenfellner M, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A.
68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer.
Eur J Nucl Med Mol Imaging. 2018 Jan 23. doi: 10.1007/s00259-018-3936-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Rowe SP, Pomper MG, Gorin MA.
Molecular Imaging of Prostate Cancer: Choosing the Right Agent.
J Nucl Med. 2018 Jan 25. pii: jnumed.117.206318. doi: 10.2967/jnumed.117.206318. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Xiao WJ, Zhu Y, Zhu Y, Dai B, Ye DW.
Evaluation of clinical staging of the American Joint Committee on Cancer (eighth edition) for prostate cancer.
World J Urol. 2018 Jan 25. doi: 10.1007/s00345-018-2183-0. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

.

Dawe DE, Ye X, Czaykowski P, Jassal D, Singh H, Skarsgard D, Aprikian A, Mahmud SM.
The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study.
Int J Cancer. 2018 Feb 6. doi: 10.1002/ijc.31295. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY

.

Miyazaki T, Ikeda K, Sato W, Horie-Inoue K, Inoue S.
Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.
Oncogenesis. 2018 Jan 24;7(1):7. doi: 10.1038/s41389-017-0022-6.
Source | Abstract | Full text | Similar articles



.

Pal SK, Patel J, He M, Foulk B, Kraft K, Smirnov DA, Twardowski P, Kortylewski M, Bhargava V, Jones JO.
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
Cancer. 2017 Dec 19. doi: 10.1002/cncr.31161. [Epub ahead of print]
Comment in: Stone L, Prostate cancer: Revealing mechanisms of resistance.
Source | Abstract | Full text | Similar articles



.

Sahin I, Mega AE, Carneiro BA.
Androgen receptor-independent prostate cancer: an emerging clinical entity.
Cancer Biol Ther. 2018 Jan 15:1-2. doi: 10.1080/15384047.2018.1423926. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Stone L.
Prostate cancer: Revealing mechanisms of resistance.
Nat Rev Urol. 2018 Jan 23. doi: 10.1038/nrurol.2018.7. [Epub ahead of print]
Comment on: Pal SK et al.,Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0.
Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Caro-Maldonado A, Camacho L, Zabala-Letona A, Torrano V, Fernández-Ruiz S, Zamacola-Bascaran K, Arreal L, Valcárcel-Jiménez L, Martín-Martín N, Flores JM, Cortazar AR, Zúñiga-García P, Arruabarrena-Aristorena A, Guillaumond F, Cabrera D, Falcón-Perez JM, Aransay AM, Gomez-Muñoz A, Olivan M, Morote J, Carracedo A.
Low-dose statin treatment increases prostate cancer aggressiveness.
Oncotarget. 2017 Oct 31;9(2):1494-1504. doi: 10.18632/oncotarget.22217. eCollection 2018 Jan 5.
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT

.

Cancian M, Renzulli JF 2nd.
Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
Urology. 2018 Jan 18. pii: S0090-4295(18)30044-X. doi: 10.1016/j.urology.2018.01.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Cooperberg MR.
How Should a Man with Prostate Cancer Choose his Surgeon?
Eur Urol. 2018 Feb 3. pii: S0302-2838(18)30074-5. doi: 10.1016/j.eururo.2018.01.020. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Pompe RS, Smith A, Bandini M, Marchioni M, Martel T, Preisser F, Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M, Shariat SF, Tilki D, Karakiewicz PI.
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study.
Prostate Cancer Prostatic Dis. 2018 Jan 16. doi: 10.1038/s41391-017-0006-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Sartor O, de Bono JS.
Metastatic Prostate Cancer.
N Engl J Med. 2018 Feb 15;378(7):645-657. doi: 10.1056/NEJMra1701695. Epub 2018 Feb 7.
Source | Abstract | Full text | Similar articles



.

Weiner AB, Kundu SD.
Prostate Cancer: A Contemporary Approach to Treatment and Outcomes.
Med Clin North Am. 2018 Mar;102(2):215-229. doi: 10.1016/j.mcna.2017.10.001. Epub 2017 Dec 24.
Source | Abstract | Full text | Similar articles



.

Xie L, Li J, Wang X.
Updates in prostate cancer detections and treatments - Messages from 2017 EAU and AUA.
Asian J Urol. 2018 Jan;5(1):3-7. doi: 10.1016/j.ajur.2017.11.004. Epub 2017 Nov 22.
Source | Abstract | Full text | Similar articles



PROGNOSIS

.

Ajib K, Zanaty M, Alnazari M, Rajih E, Hueber PA, Mansour M, Valdivieso R, Negrean C, Karakiewicz PI, Taussky D, Delouya G, El-Hakim A, Zorn KC.
Functional and oncological outcomes of salvage external beam radiotherapy following robot-assisted radical prostatectomy in a Canadian cohort.
Can Urol Assoc J. 2017 Dec 1. doi: 10.5489/cuaj.4641. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Frydenberg M, Woo HH.
Early Androgen Deprivation Therapy Improves Survival, But How Do We Determine in Whom?
Eur Urol. 2018 Jan 16. pii: S0302-2838(18)30008-3. doi: 10.1016/j.eururo.2018.01.004. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Sedlmayer F, Wenz F, Zips D, Wiegel T; Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO).
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Strahlenther Onkol. 2018 Jan 30. doi: 10.1007/s00066-018-1269-3. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Nam RK, Satkunavisam R, Chin JL, Izawa J, Trachtenberg J, Rendon R, Bell D, Singal R, Sherman C, Sugar L, Chagin K, Kattan WM.
Next-generation prostate cancer risk calculator for primary care physicians.
Can Urol Assoc J. 2017 Dec 1. doi: 10.5489/cuaj.4696. [Epub ahead of print]
Source | Abstract | Full text | Similar articles | Calculator



.

Rauscher I, Düwel C, Haller B, Rischpler C, Heck MM, Gschwend JE, Schwaiger M, Maurer T, Eiber M.
Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy.
Eur Urol. 2018 Jan 18. pii: S0302-2838(18)30010-1. doi: 10.1016/j.eururo.2018.01.006. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



.

Shou J, Zhang Q, Wang S, Zhang D.
The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
Prostate. 2018 Feb 13. doi: 10.1002/pros.23492. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT

.

Jadvar H, Chen X, Cai W, Mahmood U.
Radiotheranostics in Cancer Diagnosis and Management.
Radiology. 2018 Feb;286(2):388-400. doi: 10.1148/radiol.2017170346.
Source | Abstract | Full text | Similar articles



.

Nitipir C, Niculae D, Orlov C, Barbu MA, Popescu B, Popa AM, Pantea AMS, Stanciu AE, Galateanu B, Ginghina O, Papadakis GZ, Izotov BN, Spandidos DA, Tsatsakis AM, Negrei C.
Update on radionuclide therapy in oncology.
Oncol Lett. 2017 Dec;14(6):7011-7015. doi: 10.3892/ol.2017.7141. Epub 2017 Oct 5.
Source | Abstract | Full text | Similar articles